The XpresCheck at BOS will be in the International Arrival area, pre-security, in Terminal E, and will feature seven separate testing rooms with an anticipated capacity to administer over 400 tests per day.
The COVID-19 testing options at the new XpresCheck will include a rapid molecular COVID-19 test, the Polymerase Chain Reaction (PCR) Test, and the Blood Antibody Test. All three tests are similarly offered at XpresCheck’s first two locations in JFK International Airport (JFK) and Newark Liberty International Airport (EWR).
“We believe that our current presence in JFK and Newark, and upcoming expansion to Logan enables us to play an important role in supporting the return of domestic and international air travel to pre-pandemic levels by making sure both airport employees and travelers feel safe and confident when they come to the airport,” said Doug Satzman, XpresSpa CEO. “As previously indicated, our intention is to continue XpresCheck’s national expansion and we remain in active discussions with additional airports for further development of this concept.”